Back
Mesoblast Stock Predictions
Sponsored
MESO
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
45
MESO
Mesoblast
Last Price:
8.76
Seasonality Move:
9.84%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeMesoblast Stock Forecast
- Over the next 52 weeks, Mesoblast has on average historically risen by 36% based on the past 17 years of stock performance.
- Mesoblast has risen higher in 7 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.18%
-
Is Mesoblast Stock Undervalued?
The current Mesoblast [MESO] share price is $8.77. The Score for MESO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. - MESO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Mesoblast Stock Go Up Next Year?
- Over the next 52 weeks, Mesoblast has on average historically risen by 36% based on the past 17 years of stock performance.
Mesoblast Stock Rating
Sell
45
Mesoblast (MESO)
is a Sell
Is Mesoblast overpriced?
- Mesoblast has risen higher in 7 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.18%
Mesoblast Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Australia
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
mesoblast.com
52-Week Data
52-Week High:
11.05
52-Week Low:
1.61
Prediction Charts
Market Cap:
1B
Price in USD:
8.77
Volume:
64.98K
Beta:
1.97
Technical Analysis
SMA50:
7.93
SMA100:
7.43
SMA200:
6.00
52-Wk Change:
239.92%
Stock Predictions
-
Is Mesoblast stock public?
Yes, Mesoblast is a publicly traded company. -
What is the Mesoblast stock quote today?
The Mesoblast stock price is 8.77 USD today. -
How to buy Mesoblast stock online?
You can buy Mesoblast shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 9.57 | 9.41 | 9.60 | 9.24 |
Oct-18 | 9.74 | 9.96 | 10.12 | 9.55 |
Oct-21 | 9.95 | 9.65 | 9.99 | 9.57 |
Oct-22 | 9.51 | 9.44 | 9.68 | 9.39 |
Oct-23 | 9.33 | 9.37 | 9.46 | 9.03 |
Oct-24 | 9.00 | 8.67 | 9.05 | 8.47 |
Oct-25 | 8.55 | 8.58 | 8.78 | 8.51 |
Oct-28 | 8.58 | 9.11 | 9.25 | 8.58 |
Oct-29 | 9.07 | 9.06 | 9.11 | 8.94 |
Oct-30 | 8.97 | 8.81 | 9.10 | 8.81 |
Oct-31 | 8.50 | 8.38 | 8.76 | 8.35 |
Nov-1 | 8.35 | 8.48 | 8.61 | 7.09 |
Nov-4 | 8.40 | 8.37 | 8.64 | 8.34 |
Nov-5 | 8.50 | 8.77 | 8.81 | 8.35 |
Mesoblast Earnings
Mesoblast Earnings Report: Per Share Mesoblast Earnings Q1 Q2 Q3 and Q4 last year and next year.
Mesoblast Forecast Revenue Growth
Mesoblast Stock Analysis: Historical quarterly revenues per share for Mesoblast and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
* Mesoblast stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.